Dermata Therapeutics, Inc. — DEFA14A Filings
5 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Dermata Therapeutics, Inc. (DRMAW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Dermata Therapeutics, Inc. has filed 5 DEFA14A documents with the SEC since 2021. To view all SEC filings by Dermata Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS EX
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001641172-25-013238 | Jun 2, 2025 | — |
| DEFA14A | DEFA 14A | 0001654954-24-003658 | Mar 26, 2024 | — |
| DEFA14A | DEFA14A | 0001654954-23-009043 | Jul 12, 2023 | — |
| DEFA14A | DEFA14A | 0001654954-23-008354 | Jun 23, 2023 | — |
| DEFA14A | DEFA14A | 0001654954-22-007815 | Jun 1, 2022 | — |